Ono Pharmaceutical Co. Ltd

This study is testing whether an investigational drug called ONO-1110 can help reduce symptoms of major depressive disorder. It will involve about 100 Japanese adults with depression, comparing the drug against a placebo over 8 weeks. The main goal is to see if the drug safely le…

This study is testing whether a new oral medication called ONO-2020 can help people with mild to moderate Alzheimer's disease. About 240 participants will take either the drug or a placebo pill daily for 26 weeks to see if it improves memory and thinking skills. The main goals ar…

This study is testing whether adding an experimental drug called ONO-4578 to standard chemotherapy and immunotherapy works better for advanced stomach cancer. It involves 226 patients who haven't had chemotherapy before and compares the new combination against the standard treatm…

This study is testing an investigational drug called tirabrutinib for a rare and aggressive cancer called primary central nervous system lymphoma (PCNSL), which starts in the brain or spinal cord. It has two parts: one for patients whose cancer has returned or resisted prior trea…

This study is testing an investigational drug called ONO-1110 to see if it can safely reduce pain in Japanese adults suffering from postherpetic neuralgia, a type of long-lasting nerve pain that can follow a shingles outbreak. About 140 participants will be randomly assigned to r…

This study is testing an investigational drug called ONO-1110 to see if it can safely reduce pain and improve other symptoms in people with fibromyalgia. It will involve about 160 Japanese adults who have been diagnosed with fibromyalgia. Participants will be randomly assigned to…

This study is testing an investigational drug called ONO-1110 to see if it can safely reduce the fear and avoidance that people with social anxiety disorder experience. It will involve about 100 Japanese adults with moderate-to-severe social anxiety. Participants will be randomly…